EP2 prostanoid receptor promotes squamous cell carcinoma growth through epidermal growth factor receptor transactivation and iNOS and ERK1/2 pathways

FASEB Journal

Volumn 21, Issue 10, 2007, Pages 2418-2430

  Donnini, Sandra ^a   Finetti, Federica ^a   Solito, Raffaella ^a   Terzuoli, Erika ^a   Sacchetti, Andrea ^b   Morbidelli, Lucia ^a   Patrignani, Paola ^b   Ziche, Marina ^a  

^a UNIVERSITY OF SIENA   (Italy)

^b UNIVERSITY OF CHIETI   (Italy)

Author keywords

Invasiveness; Nitric oxide; Prostaglandin E2

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; ANTINEOPLASTIC AGENT; CYCLIC AMP DEPENDENT PROTEIN KINASE; EPIDERMAL GROWTH FACTOR RECEPTOR; GUANYLATE CYCLASE; GUANYLATE CYCLASE INHIBITOR; INDUCIBLE NITRIC OXIDE SYNTHASE; INDUCIBLE NITRIC OXIDE SYNTHASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROSTAGLANDIN E2; PROSTANOID RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVATION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SQUAMOUS CELL CARCINOMA;

CARCINOMA, SQUAMOUS CELL; CELL DIVISION; CELL LINE, TUMOR; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; IMMUNOHISTOCHEMISTRY; MITOGEN-ACTIVATED PROTEIN KINASE 3; NEOPLASM INVASIVENESS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTORS, PROSTAGLANDIN E; RECOMBINANT PROTEINS; RNA, SMALL INTERFERING; TRANS-ACTIVATION (GENETICS); TRANSFECTION;

MUS MUSCULUS;

EID: 34547758527     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fj.06-7581com     Document Type: Article

References (57)

1. Shah, J. P., Medina, J. E., Shaha, A. R., Schantz, S. P., and Marti, J. R. (1993) Cervical lymph node metastasis. Curr. Probl. Surg. 30, 1-335
2. Folkman, J. (1995) Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat. Med. 1, 27-31
3. Gallo, O., Masini, E., Morbidelli, L., Franchi, A., Fini-Storchi, I., Vergari, W. A., and Ziche, M. (1998) Role of nitric oxide in angiogenesis and tumor progression in head and neck cancer. J. Natl. Cancer Inst. 90, 587-596
4. Jenkins, D. C., Charles, I. G., Thomsen, L. L., Moss, D. W., Holmes, L. S., Baylis, S. A., Rhodes, P., Westmore, K., Emso, P. C., and Moncada, S. (1995) Role of nitric oxide in tumor growth. Proc. Natl. Acad. Sci. U. S. A. 92, 4392-4396
5. Thomsen, L. L., Miles, D. W., Happerfield, L., Bobrow, L. G., Knowles, R. G., and Moncada, S. (1995) Nitric oxide synthase activity in human breast cancer. Br. J. Cancer 72, 41-44
6. Xu, W., Liu, L. Z., Loizidou, M., Ahmed, M., and Charles, I. G. (2002) The role of nitric oxide in cancer. Cell. Res. 12, 311-320
7. Dubois, R. N., Abramson, S. B., Crofford, L., Gupta, R. A., Simon, L. S., Vande Putte, L. B., and Lipsky, P. E. (1998) Cyclooxygenase in biology and disease. FASEB J. 12, 1063-1073
8. Cao, Y., and Prescott, S. M. (2002) Many actions of Cyclooxygenase-2 in cellular dynamics and in cancer. J. Cell. Physiol. 190, 279-286
9. Park, S. W., Lee, S. L., Song, S. H., Heo, D. S., Park, B. J., Lee, D. W., Kim, K. T., and Sung, M. W. (2003) The effect of nitric oxide on cyclooxygenase-2 (COX-2) overexpression in head and neck cancer cell lines. Int. J. Cancer 107, 729-738
10. Wendum, D., Masliah, J., Trugnan, G., and Fléjou, J. F. (2004) Cyclooxygenase-2 and its role in colorectal cancer development. Virchows Arch. 445, 327-333
11. Denkert, C., Kobel, M., Pest, S., Koch, I., Berger, S., Schwabe, M., Siegert, A., Reles, A., Klosterhalfen, B., and Hauptmann, S. (2002) Expression of cyclooxygenase 2 is an independent prognostic factor in human ovarian cancer. Am. J. Pathol. 160, 893-903
12. Bae, S. H., Jung, E. S., Park, Y. M., Kim, B. S., Kim, B. K., Kim, D. G., and Ryu, W. S. (2001) Expression of cyclooxygenase-2 (COX-2) in hepatocelluler carcinoma and growth inhibition of hepatoma cell lines by a COX-2 inhibitor, NS-398. Clin. Cancer Res. 7, 1410-1418
13. Tsujii, M., Kawano, S., and DuBois, R. N. (1997) Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. Proc. Natl. Acad. Sci. U. S. A. 94, 3336-3340
14. Salvemini, D., Misko, T. P., Masferrer, J. L., Seibert, K., Currie, M. G., and Needleman, P. (1993) Nitric oxide activates cyclooxygenase enzymes. Proc. Natl. Acad. Sci. U. S. A. 90, 7240-7244
15. Salvemini, D., Currie, M. G., and Mollace, V. (1996) Nitric oxide-mediated cyclooxygenase activation. A key event in the antiplatelet effect of nitrosovasodilatators. J. Clin. Invest. 97, 2562-2568
16. 2-mediated upregulation of iNOS in murine breast cancer cells through the activation of EP4 receptors. Int. J. Cancer 108, 384-389
17. 2-dependent angiogenic switch in cyclooxygenase 2-induced breast cancer progression. Proc. Natl. Acad. Sci. U. S. A. 10, 591-596
18. Gupta, R. A., and Dubois, R. N. (2001) Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2. Nat. Rev. Cancer 1, 11-21
19. 2 increases growth and motility of colorectal carcinoma cells. J. Biol. Chem. 276, 18075-18081
20. Hata, A. N., and Breyer, R. M. (2004) Pharmacology and signaling of prostaglandin receptors: multiple roles in inflammation and immune modulation. Pharmacol. Ther. 103, 147-166
21. Regan, J. W. (2003) EP2 and EP4 prostanoid receptor signaling. Life Sci. 74, 143-153
22. Breyer, R. M., Bagdassarian, C. K., Myers, S. A., and Breyer, M. D. (2001) Prostanoid receptors: subtypes and signalling. Annu. Rev. Pharmacol. Toxicol. 41, 561-690
23. Funk, C. D., Furci, L., Fitzgerald, G. A., Grygorczyk, R., Rochette, C., Bayne, M. A., Abramovitz, M., Adam, M., and Metters, K. M. (1993) Cloning and expression of a cDNA for the human prostaglandin E receptor EP1 subtype. J. Biol. Chem. 268, 26767-26772
24. Regan, J. W., Bailey, T. J., Pepperl, D. J., Pierce, K. L., Bogardus, A. M., Donello, J. E., Fairbairn, C. E., Kedezie, K. M., Woodward, D. F., and Gil, D. W. (1994) Cloning of a novel human prostaglandin receptor with characteristics of the pharmacologically defined EP2 subtype. Mol. Pharmacol. 46, 213-220
25. Sugimoto, Y., Namba, T., Honda, A., Hayashi, Y., Negishi, M., Ichikawa, A., and Narumiya, S. (1992) Cloning and expression of a cDNA for mouse prostaglandin E receptor EP3 subtype. J. Biol. Chem. 267, 6463-6466
26. Honda, A., Sugimoto, Y., Namba, T., Watabe, A., Irie, A., Negishi, M., Narumiya, S., and Ichikawa, A. (1993) Cloning and expression of a cDNA for mouse prostaglandin E receptor EP2 subtype. J. Biol. Chem. 268, 7759-7762
27. 2 receptors in migration of murine and human breast cancer cells. Exp. Cell Res. 289, 265-274
28. Fujino, H., and Regan, J. W. (2003) Prostanoid receptors and phosphatidylinositol 3-kinase:a pathway to cancer. Trends Pharmacol. Sci. 24, 335-340
29. Majima, M., Amano, H., and Hayashi, I. (2003) Prostanoid receptor signaling relevant to tumor growth and angiogenesis. Trends Pharmacol. Sci. 24, 524-529
30. 2 transactivates EGF receptor: a novel mechanism for promoting colon cancer growth and gastrointestinal hypertrophy. Nat. Med. 8, 289-293
31. 2 regulates cell migration via the intracellular activation of the epidermal growth factor receptor. J. Biol. Chem. 278, 35451-35457
32. Sales, K. J., Maudsley, S., and Jabbour, N. H. (2005) Elevated Prostaglandin EP2 receptor in endometrial adenocarcinoma cells promotes vascular endothelial growth factor expression via cyclic 3′,5′-adenosin monophosphate-mediated transactivation of the epidermal growth factor receptor and extracellular signal-regulated kinase1/2 signaling pathways. Mol. Endocrinol. 18, 1533-1545
33. Gullick, W. J. (2001) The Type 1 growth factor receptors and their ligands considered as a complex system. Endocr. Relat. Cancer 8, 75-82
34. Yarden, Y. (2001) The EGFR family and its ligands in human cancer. signalling mechanisms and therapeutic opportunities. Eur. J. Cancer 37 S4, S3-S8
35. Lui, V. W., and Grandis, J. R. (2002) EGFR-mediated cell cycle regulation. Anticancer Res. 22, 1-11
36. Gallo, O., Fabbroni, V., Sardi, I., Magnelli, L., Boddi, V., and Franchi, A. (2002) Correlation between nitric oxide and cyclooxygenase-2 pathways in head and neck squamous cell carcinoma. Biochem. Biophys. Res. Commun. 299, 517-524
37. Chen, Z. G., Zhang, X., Li, M., Wang, Z., Wieand, H. S., Grandis, J. R., and Shin, D. M. (2004) Simultaneously targeting epidermal growth factor receptor tyrosine kinase and cyclooxygenase-2, an efficient approach to inhibition of squamous cell carcinoma of head and neck. Clin. Cancer Res. 10, 5930-5939
38. Taraboletti, G., Morbidelli, L., Donnini, S., Parenti, A., Granger, H. J., Giavazzi, R., and Ziche, M. (2000) The heparin binding 25 kDa fragment of thrombospondin-1 promotes angiogenesis and modulates gelatinase and TIMP-2 production in endothelial cells. FASEB J. 14, 1674-1676
39. Donnini, S., Morbidelli, L., Taraboletti, G., and Ziche, M. (2004) ERK1/2 and p38 MAPK regulate MMP/TIMP balance and function in response to thrombospondin-1 fragments in the microvascular endothelium. Life Sci. 74, 975-985
40. Cantara, S., Donnini, S., Morbidelli, L., Giachetti, A., Schulz, R., Memo, M., and Ziche, M. (2004) Physiological levels of amyloid peptides stimulate the angiogenic response through FGF-2. FASEB J. 18, 943-945
41. Elbashir, S. M., Harborth, J., Bechert, K., Tuschl, T., and Weber, K. (2001) Identification of essential genes in cultured mammalian cells using small interfering RNAs. J. Cell. Sci. 114, 4557-4565
42. Parenti, A., Morbidelli, L., Cui, X. L., Douglas, J. G., Hood, J. D., Granger, H. J., Ledda, F., and Ziche, M. (1998) Nitric oxide is an upstream signal of vascular endothelial growth factor-induced extracellular signal regulated kinase1/2 activation in postcapillary endothelium. J. Biol. Chem. 273, 4220-4226
43. 2. Mol. Pharmacol. 68, 251-259
44. Galisteo, M., Marc, N., Fautrel, A., Guillouzo, A., Corcos, L., and Lagadic-Gossmann, D. (1999) Involvement of cyclic nucleotide- and calcium-regulated pathways in phenobarbital-induced cytochrome P-450 3A expression in mouse primary hepatocytes. J. Pharmacol. Exp. Ther. 290, 1270-1277
45. Normanno, N., De Luca, A., Bianco, C., Strizzi, L., Mancino, M., Macello, M. R., Carotenuto, A., De Feo, G., Caponigro, F., and Salomon, D. S. (2006) Epidermal growth factor receptor (EGFR) signaling in cancer. Gene 366, 2-16
46. Jorissen, R. N., Walker, F., Pouliot, N., Garret, T. P. J., Ward, C. W., and Burgess, A. W. (2003) Epidermal growth factor receptor: mechanism of activation and signalling. Exp. Cell Res. 284, 31-53
47. Hood, J., and Granger, H. J. (1998) Protein kinase G mediates vascular endothelial growth factor-induced Raf-1 activation and proliferation in human endothelial cells. J. Biol. Chem. 273, 23504-23508
48. Jadeski, L. C., Chakraborty, C., and Lala, P. K. (2003) Nitric oxide-mediated promotion of mammary tumor cell migration requires sequential activation of nitric oxide synthase, guanylate cyclase and mitogen activated protein kinase. Int. J. Cancer 106, 496-504
49. Hood, J. D., Meininger, C. J., Ziche, M., and Granger, H. J. (1999) VEGF upregulates ecNOS message, protein, and NO production in human endothelial cells. Am. J. Physiol. 274, H1054-H1058
50. 2 synergistically enhances receptor tyrosine kinase-dependent signaling system in colon cancer cells. J. Biol. Chem. 279, 14287-14293
51. Thomas, S. M., Bhola, N. E., Zhang, Q., Contrucci, S. C., Wentzel, A. L., Freilino, M. L., Gooding, W. E., Siegfried, J. M., Chan, D. C., and Grandis, J. R. (2006) Cross-talk between G protein-coupled receptor and epidermal growth factor receptor signaling pathways contributes to growth and invasion of head and neck squamous cell carcinoma. Cancer Res. 66, 11831-1131
52. 2 activates mitogen-activated protein kinase/Erk pathway signalling and cell proliferation in non-small cell lung cancer cells in an epidermal growth factor receptor-independent manner. Cancer Res. 65, 6275-6280
53. Pai, R., Nakamura, T., Moon, W. S., and Tarnawski, A. S. (2003) Prostaglandins promote colon cancer cell invasion; signalling by cross-talk between two distinct growth factor receptors. FASEB J. 17, 1640-1647
54. Mutoh, M., Watanabe, K., Kitamura, T., Shoji, Y., Takahashi, M., Kawamori, T., Tani, K., Kobayashi, M., Maruyama, T., Kobayashi, K., et al. (2002) Involvement of prostaglandin E receptor subtype EP4 in colon carcinogenesis. Cancer Res. 62, 28-32
55. Chijiwa, T., Mishima, A., Hagiwara, M., Sano, M., Hayashi, K., Inoue, T., Naito, K., Toshioka, T., and Idaka, H. (1990) Inhibition of forskolin-induced neurite outgrowth and protein phosphorylation by a newly synthesized selective inhibitor of cyclic AMP-dependent protein kinase, N-[2-(p- bromocinnamylamino) ethyl]-5-isoquinolinesulfonamide (H-89), of PC12D pheochromocytoma cells. J. Biol. Chem. 265, 5267-5272
56. 2. J. Biol. Chem. 277, 2614-2619
57. Iwakiri, Y., Tsai, M. H., McCabe, T. J., Gratton, J. P., Fulton, D., Groszmann, R. J., and Sessa, W. C. (2002) Phosphorylation of eNOS initiates excessive NO production in early phases of portal hypertension. Am. J. Physiol. 282, H2084-H2090